» Articles » PMID: 33758081

Molecular Basis for Bordetella Pertussis Interference with Complement, Coagulation, Fibrinolytic, and Contact Activation Systems: the Cryo-EM Structure of the Vag8-C1 Inhibitor Complex

Overview
Journal mBio
Specialty Microbiology
Date 2021 Mar 24
PMID 33758081
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Complement, contact activation, coagulation, and fibrinolysis are serum protein cascades that need strict regulation to maintain human health. Serum glycoprotein, a C1 inhibitor (C1-INH), is a key regulator (inhibitor) of serine proteases of all the above-mentioned pathways. Recently, an autotransporter protein, virulence-associated gene 8 (Vag8), produced by the whooping cough pathogen, , was shown to bind to C1-INH and interfere with its function. Here, we present the structure of the Vag8-C1-INH complex determined using cryo-electron microscopy at a 3.6-Å resolution. The structure shows a unique mechanism of C1-INH inhibition not employed by other pathogens, where Vag8 sequesters the reactive center loop of C1-INH, preventing its interaction with the target proteases. The structure of a 10-kDa protein complex is one of the smallest to be determined using cryo-electron microscopy at high resolution. The structure reveals that C1-INH is sequestered in an inactivated state by burial of the reactive center loop in Vag8. By so doing, the bacterium is able to simultaneously perturb the many pathways regulated by C1-INH. Virulence mechanisms such as the one described here assume more importance given the emerging evidence about dysregulation of contact activation, coagulation, and fibrinolysis leading to COVID-19 pneumonia.

Citing Articles

The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation.

Garrigues R, Garrison M, Garcia B J Immunol. 2024; 213(5):718-729.

PMID: 38995166 PMC: 11333171. DOI: 10.4049/jimmunol.2400194.


The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.

Avdonin P, Blinova M, Generalova G, Emirova K, Avdonin P Biomolecules. 2024; 14(1).

PMID: 38254639 PMC: 10813406. DOI: 10.3390/biom14010039.


Crystal structure of a subtilisin-like autotransporter passenger domain reveals insights into its cytotoxic function.

Hor L, Pilapitiya A, McKenna J, Panjikar S, Anderson M, Desvaux M Nat Commun. 2023; 14(1):1163.

PMID: 36859523 PMC: 9977779. DOI: 10.1038/s41467-023-36719-2.


Phylogenetic Classification and Functional Review of Autotransporters.

Clarke K, Hor L, Pilapitiya A, Luirink J, Paxman J, Heras B Front Immunol. 2022; 13:921272.

PMID: 35860281 PMC: 9289746. DOI: 10.3389/fimmu.2022.921272.

References
1.
Dijk M, Holkers J, Voskamp P, Giannetti B, Waterreus W, van Veen H . How Dextran Sulfate Affects C1-inhibitor Activity: A Model for Polysaccharide Potentiation. Structure. 2016; 24(12):2182-2189. DOI: 10.1016/j.str.2016.09.013. View

2.
Thorsen S, Philips M . Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor. Biochim Biophys Acta. 1984; 802(1):111-8. DOI: 10.1016/0304-4165(84)90040-0. View

3.
Domenech de Celles M, Magpantay F, King A, Rohani P . The impact of past vaccination coverage and immunity on pertussis resurgence. Sci Transl Med. 2018; 10(434). PMC: 6063734. DOI: 10.1126/scitranslmed.aaj1748. View

4.
Klein N, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R . Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012; 367(11):1012-9. DOI: 10.1056/NEJMoa1200850. View

5.
Dunkelberger J, Song W . Complement and its role in innate and adaptive immune responses. Cell Res. 2009; 20(1):34-50. DOI: 10.1038/cr.2009.139. View